Healthcare Value Capital’s ProShares UltraPro Short S&P 500 SPXU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$2.63M Buy
7,500
+5,000
+200% +$1.65M 5.19% 10
2021
Q2
$911K Sell
2,500
-2,500
-50% -$1M 1.82% 18
2021
Q1
$2.37M Buy
+5,000
New +$2.65M 5.27% 8
2020
Q4
Sell
-1,000
Closed -$870K 18
2020
Q3
$870K Sell
1,000
-1,000
-50% -$940K 2.87% 12
2020
Q2
$2.36M Buy
2,000
+1,250
+167% +$1.9M 6.03% 8
2020
Q1
$1.81M Buy
+750
New +$1.68M 3.04% 16

Other funds holding SPXU

Healthcare Value Capital's SPXU Position: Q4 2020 in Review

Healthcare Value Capital sold out of ProShares UltraPro Short S&P 500 (SPXU) in Q4 2020, closing a stake of 2,500 shares — an estimated $2.17M sold.

Healthcare Value Capital first reported a position in SPXU in Q1 2020 and held it in 3 quarters. The position peaked at $3.62M in Q1 2020. 60 funds tracked by Wall St. Rank hold SPXU as of Q4 2020.

  • Healthcare Value Capital reported no remaining ProShares UltraPro Short S&P 500 position as of Q4 2020 after selling out during the quarter.
  • Healthcare Value Capital sold 2,500 ProShares UltraPro Short S&P 500 shares in Q4 2020, an estimated $2.17M.
  • Healthcare Value Capital first reported a position in ProShares UltraPro Short S&P 500 in Q1 2020 and held it in 3 quarters.
  • Healthcare Value Capital's ProShares UltraPro Short S&P 500 position peaked at $3.62M in Q1 2020.
  • 60 funds tracked by Wall St. Rank held ProShares UltraPro Short S&P 500 as of Q4 2020.

Based on Healthcare Value Capital's 13F filing for Q4 2020, filed 16 Feb 2021.